Send Email

Location

Rua Câmara Pestana, 6 - Ed. Cedoc II
Phone: 351218803000

Susana Nunes Silva

Investigador  Investigador Doutorado

Susana Silva holds a PhD in Life Sciences in the genetics field. During her professional career, she has been dedicated to the study of susceptibility and genetic variants in breast and thyroid cancer with a special focus on DNA repair.

  • Pimenta I, Mateus H, Rodrigues-Manica S, Pinheiro-Torres R, Neto A, Domingues L, Lage Crespo C, Sardoo A, Machado P, Branco JC, Silva SN, Pimentel-Santos FM., The Effect of ACTN3 and VDR Polymorphisms on Skeletal Muscle Performance in Axial Spondyloarthropathies. Front Genet. 2021 Aug 11;12:688984. doi: 10.3389/fgene.2021.688984. eCollection 2021. (https://www.frontiersin.org/articles/10.3389/fgene.2021.688984/full)
  • Silva SN, Gomes BC, André S, Félix A, Rodrigues AS, Rueff J., Male and female breast cancer: the two faces of the same genetic susceptibility coin. Breast Cancer Res Treat. 2021 Jul;188(1):295-305. doi: 10.1007/s10549-021-06159-x. Epub 2021 May 3. (https://link.springer.com/article/10.1007%2Fs10549-021-06159-x )
  • Silva SN, Special Issue: Genetic Perspectives in Thyroid Cancer. Genes (Basel). 2021 Jan 20;12(2):126. doi: 10.3390/genes12020126. (https://www.mdpi.com/2073-4425/12/2/126 )
  • Santos LS, Gil OM, Silva SN, Gomes BC, Ferreira TC, Limbert E and Rueff J, Micronuclei formation upon radioiodine therapy for well-differentiated thyroid cancer: The influence of DNA repair genes variants. Sep 2020, Genes. 11, 9, p. 1-24 24 p., 1083. (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565468/ )
  • Santos LS, Gomes BC, Bastos HN, Gil OM, Azevedo AP, Ferreira TC, Limbert E, Silva SN, Rueff J. Thyroid Cancer: The Quest for Genetic Susceptibility Involving DNA Repair Genes. (2019) Genes (Basel). 1:10(8) doi: 10.3390/genes10080586. (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722859/ )
  • Azevedo AP, Silva SN, De Lima JP, Reichert A, Lima F, Júnior E, Rueff J. Effects of polymorphic DNA genes involved in BER and caspase pathways on the clinical outcome of myeloproliferative neoplasms under treatment with hydroxyurea. (2018) Molecular Medicine Reports 18(6): 5243-5255. (DOI:10.3892/mmr_2018.9535) (https://www.spandidos-publications.com/10.3892/mmr.2018.9535#)
ResearcherID: A-9678-2013 ORCID ID: 0000-0002-9122-0732 Scopus Author ID: 7203043130 Ciência ID: 8C1F-BB2F-44E3